Scholarlink

Background <p>Bronchial asthma is a common chronic condition frequently managed with corticosteroids, β2 receptor agonists, or their combination. While these therapies effectively control respiratory symptoms, emerging evidence suggests they may adversely affect oral and salivary gland health. However, most existing studies focus on inhalation-related tooth erosion or xerostomia, with limited histological evidence on glandular changes. This study uniquely investigates the direct impact of combination therapy of salmeterol and fluticasone propionate on the parotid glands using histological and immunohistochemical analyses.</p> Objective <p>to evaluate the possible effect of long-acting β2-agonist (Salmeterol) and corticosteroid (Fluticasone propionate) combination treatment on parotid glands and assess the histological and immunohistochemical changes.</p> Materials and methods <p>36 male albino rats were allocated into control and experimental groups. The experimental group received daily intraperitoneal injections of a combination of salmeterol and fluticasone propionate powder at a dosage of 0.55&#xa0;mg/kg/day, while the control group was administered an equal volume of saline. Nine rats from each group were sacrificed at 14 and 25 days of treatment. The parotid glands were dissected at each time point and subjected to histological examination using H&amp;E and immunohistochemical staining for α-SMA.</p> Results <p>Histological examination of group II after 14 days, serous acini appeared spherical with hyperchromatic nuclei, while ducts showed epithelial thinning and stagnant secretion. By 25 days, acini became irregular with cytoplasmic vacuolations, increased spacing, and inflammatory infiltration. Engorged blood vessels were observed. Immunohistochemical results using anti-α-SMA staining proved a significant decrease in myoepithelial activity compared to the control group.</p> Conclusions <p>Prolonged combination treatment leads to quantitative and qualitative changes in parotid salivary glands, potentially impacting oral and dental health. Therefore, greater attention should be given to the oral health of individuals using this medication.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effect of long-acting β2-agonist and corticosteroid combination treatment on parotid glands of rats (histological and immunohistochemical study)

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月5日

查看全文
  • Lobna Mohamed Nabil,
  • Dalia Riad

摘要

Background

Bronchial asthma is a common chronic condition frequently managed with corticosteroids, β2 receptor agonists, or their combination. While these therapies effectively control respiratory symptoms, emerging evidence suggests they may adversely affect oral and salivary gland health. However, most existing studies focus on inhalation-related tooth erosion or xerostomia, with limited histological evidence on glandular changes. This study uniquely investigates the direct impact of combination therapy of salmeterol and fluticasone propionate on the parotid glands using histological and immunohistochemical analyses.

Objective

to evaluate the possible effect of long-acting β2-agonist (Salmeterol) and corticosteroid (Fluticasone propionate) combination treatment on parotid glands and assess the histological and immunohistochemical changes.

Materials and methods

36 male albino rats were allocated into control and experimental groups. The experimental group received daily intraperitoneal injections of a combination of salmeterol and fluticasone propionate powder at a dosage of 0.55 mg/kg/day, while the control group was administered an equal volume of saline. Nine rats from each group were sacrificed at 14 and 25 days of treatment. The parotid glands were dissected at each time point and subjected to histological examination using H&E and immunohistochemical staining for α-SMA.

Results

Histological examination of group II after 14 days, serous acini appeared spherical with hyperchromatic nuclei, while ducts showed epithelial thinning and stagnant secretion. By 25 days, acini became irregular with cytoplasmic vacuolations, increased spacing, and inflammatory infiltration. Engorged blood vessels were observed. Immunohistochemical results using anti-α-SMA staining proved a significant decrease in myoepithelial activity compared to the control group.

Conclusions

Prolonged combination treatment leads to quantitative and qualitative changes in parotid salivary glands, potentially impacting oral and dental health. Therefore, greater attention should be given to the oral health of individuals using this medication.